The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Amgen Inc. maintained structural consistency in its Risk Factors section between the 2024 and 2025 10-K filings, with no new risks added, no existing risks removed, and no substantive modifications to disclosed risks. All six risk factors from the prior year remained unchanged in both content and presentation.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.